Gene |
Gene
Mutation Frequency |
COSMIC ID |
AA Mutation |
Type of Mutation |
Frequency of
Unique Mutation (%) |
Drug
Resistance |
Drug
Sensitivity |
EGFR |
25% |
COSM12979 |
p.L858R |
Substitution - Missense |
0.0686 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM13243 |
p.?del |
Deletion - In frame |
6.1082 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM12980 |
p.E746_A750del |
Deletion - In frame |
3.0723 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM6224 |
p.L858R |
Subsitituion-Missense |
2.5148 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM6223 |
p.E746_A750delELREA |
Deletion - In frame |
1.5876 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM21943 |
p.T790M |
Substitution - Missense |
0.8787 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM13173 |
p.L861Q |
Substitution - Missense |
0.2727 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM13564 |
p.L747_P753>S |
Complex - deletion inframe |
0.2121 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM13448 |
p.G719A |
Substitution - Missense |
0.1212 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM6240 |
p.T790M |
Substitution - Missense |
0.0909 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM18486 |
p.S768I |
Substitution - Missense |
0.0879 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM20881 |
p.G719C |
Substitution - Missense |
0.0424 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM12384 |
p.E746_S752>V |
Complex - deletion inframe |
0.0727 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM6213 |
p.L861Q |
Substitution - Missense |
0.0667 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM26352 |
p.V769_D770insASV |
Insertion - In frame |
0.0515 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM25873 |
p.P772_H773insPR |
Insertion - In frame |
0.0333 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM6252 |
p.G719S |
Substitution - Missense |
0.0303 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM18490 |
p.D770_N771insSVD |
Insertion - In frame |
0.0303 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM12988 |
c.2125G>A |
Substitution |
0.0242 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM23623 |
p.H773R |
Substitution - Missense |
0.0212 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM13424 |
p.L833V |
Substitution - Missense |
0.0212 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM12678 |
p.E746_T751>A |
Complex - deletion inframe |
0.0212 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM28009 |
p.K745_A750del |
Deletion - In frame |
0.0212 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM18491 |
p.H773_V774insNPH |
Insertion - In frame |
0.0212 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM24573 |
p.L747_T751>P |
Complex - deletion inframe |
0.0182 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM86965 |
p.D770>GY |
Complex - insertion inframe |
0.0151 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM28574 |
p.P848L |
Substitution - Missense |
0.0242 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM27111 |
p.A871G |
Substitution - Missense |
0.0151 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM30754 |
p.L747P |
Substitution - Missense |
0.0151 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM12376 |
p.V769_D770insASV |
Insertion - In frame |
0.0151 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM23571 |
p.L747_T751delLREAT |
Deletion - In frame |
0.0151 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
EGFR |
25% |
COSM27101 |
p.L747_E749del |
Deletion - In frame |
0.0151 |
Afatinib, Erlotinib |
Afatinib, Erlotinib, Gefitinib, BIBW2992 |
TP53 |
25% |
COSM43617 |
p.? |
Substitution - Missense |
9.8864 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM10660 |
p.R273H |
Substitution - Missense |
1.6828 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM10779 |
p.R273L |
Substitution - Missense |
0.5469 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM10670 |
p.V157F |
Substitution - Missense |
0.4207 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM96438 |
p.Y220C |
Substitution - Missense |
0.2945 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM11081 |
p.G245C |
Substitution - Missense |
0.2945 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM43629 |
p.R249W |
Substitution - Missense |
0.2524 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM45647 |
p.I254F |
Substitution - Missense |
0.2524 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM10662 |
p.R248Q |
Substitution - Missense |
0.2524 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM44054 |
p.L252F |
Substitution - Missense |
0.2524 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM10991 |
p.K132N |
Substitution - Missense |
0.2524 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM10808 |
p.Y163C |
Substitution - Missense |
0.2524 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM6815 |
p.G154V |
Substitution - Missense |
0.2103 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM6549 |
p.R248L |
Substitution - Missense |
0.1683 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM10656 |
p.R248W |
Substitution - Missense |
0.1683 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM10817 |
p.R249S |
Substitution - Missense |
0.1683 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM10758 |
p.Y220C |
Substitution - Missense |
0.1683 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM10714 |
p.R158L |
Substitution - Missense |
0.1262 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM10785 |
p.R249S |
Substitution - Missense |
0.1262 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
TP53 |
25% |
COSM10749 |
p.C277F |
Substitution - Missense |
0.1262 |
Nutlin-3a+ |
Thapsigargin, EpothiloneB, OSU-03012, GNF-2 |
KRAS |
17% |
COSM516 |
p.G12C |
Substitution - Missense |
7.3957 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM520 |
p.G12V |
Substitution - Missense |
4.0905 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM521 |
p.G12D |
Substitution - Missense |
3.8326 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM522 |
p.G12A |
Substitution - Missense |
1.2307 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM517 |
p.G12S |
Substitution - Missense |
0.6095 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib,
PD-173074, AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244,
OSI-906, TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM527 |
p.G13C |
Substitution - Missense |
0.6095 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM532 |
p.G13D |
Substitution - Missense |
0.504 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM518 |
p.G12R |
Substitution - Missense |
0.4219 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM14201 |
p.Q61H |
Substitution - Missense |
0.1641 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM21618 |
COSM21618 |
Substitution - Missense |
0.1406 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM25877 |
p.G12D |
Substitution - Missense |
0.1289 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM25878 |
p.G12C |
Substitution - Missense |
0.1055 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM555 |
p.Q61H |
Substitution - Missense |
0.0703 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM549 |
p.Q61K |
Substitution - Missense |
0.0586 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM552 |
p.Q61R |
Substitution - Missense |
0.0586 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM25881 |
p.G12A |
Substitution - Missense |
0.0469 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM25879 |
p.G12V |
Substitution - Missense |
0.0469 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM512 |
p.G12 |
Substitution - Missense |
0.0469 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM4169642 |
p.G13C |
Substitution - Missense |
0.0234 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM18793 |
p.G13D |
Substitution - Missense |
0.0234 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM1685355 |
p.G13F |
Substitution - Missense |
0.0234 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM553 |
p.Q61L |
Substitution - Missense |
0.0234 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM551 |
p.Q61P |
Substitution - Missense |
0.0117 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM1666976 |
p.V14L |
Substitution - Missense |
0.0117 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM1666974 |
p.G13Y |
Substitution - Missense |
0.0117 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM4944035 |
COSM4944035 |
Substitution - Missense |
0.0117 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM529 |
p.G13R |
Substitution - Missense |
0.0117 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM25880 |
p.G12S |
Substitution - Missense |
0.0117 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM550 |
p.Q61E |
Substitution - Missense |
0.0117 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
KRAS |
17% |
COSM12721 |
p.G13V |
Substitution - Missense |
0.0117 |
Vorinostat, NVP-BEZ235, AZD8055, Azitinib, PD-173074,
AZD6482, GDC0941, Methotrexate |
PD-0325901, AZ628, CI-1040, RDEA119, AZD6244, OSI-906,
TW37, Z-LLNle-CHO, TFH535, Methotrexate, JNK-9L |
ALK |
15% |
COSM4422786 |
p.L1196M |
Substitution - Missense |
0.8696 |
17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib,
Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB
216763, ABT-263 |
PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib,
Roscovitine |
ALK |
15% |
COSM4422788 |
p.S1206Y |
Substitution - Missense |
0.8696 |
17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib,
Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB
216763, ABT-263 |
PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib,
Roscovitine |
ALK |
15% |
COSM28498 |
p.I1171N |
Substitution - Missense |
0.8696 |
17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib,
Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB
216763, ABT-263 |
PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib,
Roscovitine |
ALK |
15% |
COSM97185 |
p.L1152R |
Substitution - Missense |
0.8696 |
17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib,
Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB
216763, ABT-263 |
PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib,
Roscovitine |
ALK |
15% |
COSM99137 |
p.L1196M |
Substitution - Missense |
0.8696 |
17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib,
Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB
216763, ABT-263 |
PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib,
Roscovitine |
ALK |
15% |
COSM4422790 |
p.F1174C |
Substitution - Missense |
0.8696 |
17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib,
Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB
216763, ABT-263 |
PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib,
Roscovitine |
ALK |
15% |
COSM4422791 |
p.F1174V |
Substitution - Missense |
0.8696 |
17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib,
Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB
216763, ABT-263 |
PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib,
Roscovitine |
ALK |
15% |
COSM99136 |
p.C1156Y |
Substitution - Missense |
0.8696 |
17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib,
Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB
216763, ABT-263 |
PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib,
Roscovitine |
ALK |
15% |
COSM4440758 |
p.I1171S |
Substitution - Missense |
0.8696 |
17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib,
Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB
216763, ABT-263 |
PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib,
Roscovitine |
ALK |
15% |
COSM4422787 |
p.G1269A |
Substitution - Missense |
1.7391 |
17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib,
Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB
216763, ABT-263 |
PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib,
Roscovitine |
ALK |
15% |
COSM1169707 |
p.G1269A |
Substitution - Missense |
2.6087 |
17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib,
Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB
216763, ABT-263 |
PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib,
Roscovitine |
ALK |
15% |
COSM4422789 |
p.G1202R |
Substitution - Missense |
2.6087 |
17-AAG, ZM447439, p38, JNK2, AZ628, Crizotinib,
Seliciclib, GW 441756, Methotrexate, CEP-701, Tretinoin, SB
216763, ABT-263 |
PD-0332991, JNK Inhibitor VIII, Vinorelbine, Olaparib,
Roscovitine |
CDKN2A |
11% |
COSM13598 |
p.? |
Unknown |
3.01 |
Cytarabine+, Docetaxel, Midostaurin, Temsirolimus |
Salubrinal, ABT-263, PAC-1, Nutlin-3a |
CDKN2A |
11% |
COSM12525 |
p.? |
Unknown |
1.4214 |
Cytarabine+, Docetaxel, Midostaurin, Temsirolimus |
Salubrinal, ABT-263, PAC-1, Nutlin-3a |
CDKN2A |
11% |
COSM12526 |
p.0? |
Whole gene deletion |
1.1706 |
Cytarabine+, Docetaxel, Midostaurin, Temsirolimus |
Salubrinal, ABT-263, PAC-1, Nutlin-3a |
CDKN2A |
11% |
COSM12524 |
p.? |
Unknown |
1.087 |
Cytarabine+, Docetaxel, Midostaurin, Temsirolimus |
Salubrinal, ABT-263, PAC-1, Nutlin-3a |
CDKN2A |
11% |
COSM12523 |
p.? |
Unknown |
0.4181 |
Cytarabine+, Docetaxel, Midostaurin, Temsirolimus |
Salubrinal, ABT-263, PAC-1, Nutlin-3a |
CDKN2A |
11% |
COSM13281 |
p.E69* |
Subsititution-Missense |
0.3344 |
Cytarabine+, Docetaxel, Midostaurin, Temsirolimus |
Salubrinal, ABT-263, PAC-1, Nutlin-3a |
CDKN2A |
11% |
COSM13587 |
p.0? |
Whole gene deletion |
0.3344 |
Cytarabine+, Docetaxel, Midostaurin, Temsirolimus |
Salubrinal, ABT-263, PAC-1, Nutlin-3a |
CDKN2A |
11% |
COSM13964 |
p.Y44* |
Substitution-Missense |
0.2508 |
Cytarabine+, Docetaxel, Midostaurin, Temsirolimus |
Salubrinal, ABT-263, PAC-1, Nutlin-3a |
CDKN2A |
11% |
COSM13489 |
p.D108Y |
Substitution-Missense |
0.2508 |
Cytarabine+, Docetaxel, Midostaurin, Temsirolimus |
Salubrinal, ABT-263, PAC-1, Nutlin-3a |
CDKN2A |
11% |
COSM13530 |
p.? |
Unknown |
0.2508 |
Cytarabine+, Docetaxel, Midostaurin, Temsirolimus |
Salubrinal, ABT-263, PAC-1, Nutlin-3a |
CDKN2A |
11% |
COSM12547 |
p.W110* |
Substitution- Nonsense |
0.1672 |
Cytarabine+, Docetaxel, Midostaurin, Temsirolimus |
Salubrinal, ABT-263, PAC-1, Nutlin-3a |
CDKN2A |
11% |
COSM12476 |
p.P114L |
Substitution-Missense |
0.1672 |
Cytarabine+, Docetaxel, Midostaurin, Temsirolimus |
Salubrinal, ABT-263, PAC-1, Nutlin-3a |
CDKN2A |
11% |
COSM12473 |
p.R58* |
Substitution- Nonsense |
0.1672 |
Cytarabine+, Docetaxel, Midostaurin, Temsirolimus |
Salubrinal, ABT-263, PAC-1, Nutlin-3a |
CDKN2A |
11% |
COSM13567 |
p.C72* |
Substitution- Nonsense |
0.1672 |
Cytarabine+, Docetaxel, Midostaurin, Temsirolimus |
Salubrinal, ABT-263, PAC-1, Nutlin-3a |
CDKN2A |
11% |
COSM13717 |
p.E69V |
Substitution-Missense |
0.0836 |
Cytarabine+, Docetaxel, Midostaurin, Temsirolimus |
Salubrinal, ABT-263, PAC-1, Nutlin-3a |
ATM |
7% |
COSM12793 |
p.E848Q |
Substitution - Missense |
2.8571 |
AZD6738 |
AZD6738 |
ATM |
7% |
COSM12791 |
p.T2666A |
Substitution - Missense |
2.8571 |
AZD6738 |
AZD6738 |
ATM |
7% |
COSM12792 |
p.L1794L |
Substitution - coding silent |
2.8571 |
AZD6738 |
AZD6738 |
ATM |
7% |
COSM210743 |
p.V997fs*1 |
Unknown |
1.4286 |
AZD6738 |
AZD6738 |
ATM |
7% |
COSM210744 |
p.N429fs*7 |
Unknown |
1.4286 |
AZD6738 |
AZD6738 |
UBR5 |
5% |
COSM23129 |
p.A414T |
Substitution - Missense |
1.0753 |
RF-C11 |
RF-C11 |
UBR5 |
5% |
COSM3269474 |
p.Q1533* |
Substitution - Nonsense |
1.0753 |
RF-C11 |
RF-C11 |
UBR5 |
5% |
COSM23126 |
p.V968I |
Substitution - Missense |
1.0753 |
RF-C11 |
RF-C11 |
UBR5 |
5% |
COSM26913 |
p.A870S |
Substitution - Missense |
1.0753 |
RF-C11 |
RF-C11 |
UBR5 |
5% |
COSM25327 |
p.F2023F |
Substitution - coding silent |
1.0753 |
RF-C11 |
RF-C11 |
CBL |
4% |
COSM41272 |
p.V391I |
Substitution - Missense |
1.0638 |
Erlotinib |
Erlotinib |
CBL |
4% |
COSM41274 |
p.A848T |
Substitution - Missense |
0.5319 |
Erlotinib |
Erlotinib |
CBL |
4% |
COSM41270 |
p.H94Y |
Substitution - Missense |
0.5319 |
Erlotinib |
Erlotinib |
CBL |
4% |
COSM41591 |
p.D460delD |
Deletion - In frame |
0.5319 |
Erlotinib |
Erlotinib |
CBL |
4% |
COSM41273 |
p.R830K |
Substitution - Missense |
0.5319 |
Erlotinib |
Erlotinib |
CBL |
4% |
COSM41269 |
p.S80N |
Substitution - Missense |
0.5319 |
Erlotinib |
Erlotinib |
CBL |
4% |
COSM41275 |
p.W802* |
Substitution - Missense |
0.5319 |
Erlotinib |
Erlotinib |
CBL |
4% |
COSM41271 |
p.Q249E |
Substitution - Missense |
0.5319 |
Erlotinib |
Erlotinib |
PIK3CA |
2% |
COSM29328 |
p.E545K |
Substitution - Missense |
0.5161 |
Methotrexate, PAC-1, VX-702 |
AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
PIK3CA |
2% |
COSM29329 |
p.E542K |
Substitution - Missense |
0.3226 |
Methotrexate, PAC-1, VX-702 |
AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
PIK3CA |
2% |
COSM29325 |
p.H1047R |
Substitution - Missense |
0.1613 |
Methotrexate, PAC-1, VX-702 |
AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
PIK3CA |
2% |
COSM763 |
p.E545K |
Substitution - Missense |
0.0968 |
Methotrexate, PAC-1, VX-702 |
AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
PIK3CA |
2% |
COSM30744 |
p.H1047L |
Substitution - Missense |
0.0968 |
Methotrexate, PAC-1, VX-702 |
AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
PIK3CA |
2% |
COSM29326 |
p.H1047Y |
Substitution - Missense |
0.0968 |
Methotrexate, PAC-1, VX-702 |
AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
PIK3CA |
2% |
COSM775 |
p.H1047R |
Substitution - Missense |
0.0645 |
Methotrexate, PAC-1, VX-702 |
AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
PIK3CA |
2% |
COSM29313 |
p.M1043I |
Substitution - Missense |
0.0645 |
Methotrexate, PAC-1, VX-702 |
AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
PIK3CA |
2% |
COSM86997 |
p.G1049S |
Substitution - Missense |
0.0645 |
Methotrexate, PAC-1, VX-702 |
AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
PIK3CA |
2% |
COSM760 |
p.E542K |
Substitution - Missense |
0.0645 |
Methotrexate, PAC-1, VX-702 |
AZD6482, AKTinhibitorVIII, AZD6482, Lapatinib, WZ1-84 |
STK11 |
2% |
COSM21212 |
p.E57fs*7 |
Deletion - Frameshift |
0.4435 |
Metformin, Bryostatin, GW441756 |
Metformin, Bryostatin, GW441756 |
STK11 |
2% |
COSM21360 |
p.F354L |
Substitution - Missense |
0.2217 |
Metformin, Bryostatin, GW441756 |
Metformin, Bryostatin, GW441756 |
STK11 |
2% |
COSM25854 |
p.R409W |
Substitution - Missense |
0.2217 |
Metformin, Bryostatin, GW441756 |
Metformin, Bryostatin, GW441756 |
STK11 |
2% |
COSM210753 |
p.D194Y |
Substitution - Missense |
0.2217 |
Metformin, Bryostatin, GW441756 |
Metformin, Bryostatin, GW441756 |
RET |
2% |
COSM1716552 |
p.E623* |
Substitution - Nonsense |
0.3484 |
Vandetanib, Vandetanib, Cabozantinib |
Vandetanib, Vandetanib, Cabozantinib |
RET |
2% |
COSM1716551 |
p.I364fs*? |
Unknown |
0.3484 |
Vandetanib, Vandetanib, Cabozantinib |
Vandetanib, Vandetanib, Cabozantinib |
RET |
2% |
COSM1716550 |
p.R67H |
Substitution - Missense |
0.3484 |
Vandetanib, Vandetanib, Cabozantinib |
Vandetanib, Vandetanib, Cabozantinib |
RET |
2% |
COSM538683 |
p.R77L |
Substitution - Missense |
0.3484 |
Vandetanib, Vandetanib, Cabozantinib |
Vandetanib, Vandetanib, Cabozantinib |
RET |
2% |
COSM12992 |
p.R348R |
Substitution - coding silent |
0.3484 |
Vandetanib, Vandetanib, Cabozantinib |
Vandetanib, Vandetanib, Cabozantinib |
BRAF |
1% |
COSM1131 |
p.V600E |
Substitution - Missense |
0.4796 |
Axitinib, GDC0941, BIBW2992, AZD6482 |
AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244,
CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
BRAF |
1% |
COSM476 |
p.V600E |
Substitution - Missens |
0.2998 |
Axitinib, GDC0941, BIBW2992, AZD6482 |
AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244,
CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
BRAF |
1% |
COSM470 |
p.L597V |
Substitution - Missense |
0.1199 |
Axitinib, GDC0941, BIBW2992, AZD6482 |
AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244,
CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
BRAF |
1% |
COSM460 |
p.G469A |
Substitution - Missense |
0.1199 |
Axitinib, GDC0941, BIBW2992, AZD6482 |
AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244,
CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
BRAF |
1% |
COSM460 |
p.G469A |
Substitution - Missense |
0.06 |
Axitinib, GDC0941, BIBW2992, AZD6482 |
AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244,
CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
BRAF |
1% |
COSM29610 |
p.G466V |
Substitution - Missense |
0.06 |
Axitinib, GDC0941, BIBW2992, AZD6482 |
AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244,
CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
BRAF |
1% |
COSM34031 |
p.L485_P490>Y |
Complex - deletion inframe |
0.03 |
Axitinib, GDC0941, BIBW2992, AZD6482 |
AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244,
CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
BRAF |
1% |
COSM36377 |
p.G466A |
Substitution - Missense |
0.03 |
Axitinib, GDC0941, BIBW2992, AZD6482 |
AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244,
CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
BRAF |
1% |
COSM26457 |
p.D594N |
Substitution - Missense |
0.03 |
Axitinib, GDC0941, BIBW2992, AZD6482 |
AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244,
CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
BRAF |
1% |
COSM1155715 |
p.G469del |
Deletion - In frame |
0.03 |
Axitinib, GDC0941, BIBW2992, AZD6482 |
AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244,
CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
BRAF |
1% |
COSM36245 |
p.T599_V600insT |
Insertion - In frame |
0.03 |
Axitinib, GDC0941, BIBW2992, AZD6482 |
AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244,
CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
BRAF |
1% |
COSM27329 |
p.D594G |
Substitution - Missense |
0.03 |
Axitinib, GDC0941, BIBW2992, AZD6482 |
AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244,
CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
BRAF |
1% |
COSM1155714 |
p.G466R |
Substitution - Missense |
0.03 |
Axitinib, GDC0941, BIBW2992, AZD6482 |
AZ628+, PLX4720, SB590885, RDEA119, PD-0325901, AZD6244,
CI-1040, Nutlin-3a, CHIR-99021, ObatoclaxMesylate, Docetaxel |
NRAS |
1% |
COSM584 |
p.Q61R |
Substitution - Missense |
0.2149 |
Gefitinib, Imatinib, Lenalidomide, AZD-0530 |
MitomycinC, AZD6244, OSU-03012, CI-1040 |
NRAS |
1% |
COSM580 |
p.Q61K |
Substitution - Missense |
0.2149 |
Gefitinib, Imatinib, Lenalidomide, AZD-0530 |
MitomycinC, AZD6244, OSU-03012, CI-1040 |
NRAS |
1% |
COSM36378 |
p.Q61L |
Substitution - Missense |
0.1612 |
Gefitinib, Imatinib, Lenalidomide, AZD-0530 |
MitomycinC, AZD6244, OSU-03012, CI-1040 |
NRAS |
1% |
COSM583 |
p.Q61L |
Substitution - Missense |
0.2149 |
Gefitinib, Imatinib, Lenalidomide, AZD-0530 |
MitomycinC, AZD6244, OSU-03012, CI-1040 |
NRAS |
1% |
COSM589 |
p.S65C |
Substitution - Missense |
0.1075 |
Gefitinib, Imatinib, Lenalidomide, AZD-0530 |
MitomycinC, AZD6244, OSU-03012, CI-1040 |
NRAS |
1% |
COSM585 |
p.Q61H |
Substitution - Missense |
0.0537 |
Gefitinib, Imatinib, Lenalidomide, AZD-0530 |
MitomycinC, AZD6244, OSU-03012, CI-1040 |
MET |
1% |
COSM249781 |
p.? |
Unknown |
0.2457 |
Lapatinib, Erlotinib, Crizotinib |
Lapatinib, Erlotinib, Crizotinib, Onartuzumab |
MET |
1% |
COSM41592 |
p.L211W |
Substitution - Missense |
0.0819 |
Lapatinib, Erlotinib, Crizotinib |
Lapatinib, Erlotinib, Crizotinib, Onartuzumab |
MET |
1% |
COSM29311 |
p.982_1028del47 |
Deletion - In frame |
0.0819 |
Lapatinib, Erlotinib, Crizotinib |
Lapatinib, Erlotinib, Crizotinib, Onartuzumab |
MET |
1% |
COSM12876 |
p.S283S |
Substitution - coding silent |
0.0819 |
Lapatinib, Erlotinib, Crizotinib |
Lapatinib, Erlotinib, Crizotinib, Onartuzumab |
MET |
1% |
COSM29310 |
p.Q1029_G1105del |
Deletion - In frame |
0.0819 |
Lapatinib, Erlotinib, Crizotinib |
Lapatinib, Erlotinib, Crizotinib, Onartuzumab |
MET |
1% |
COSM29312 |
p.982_1028del47 |
Deletion - In frame |
0.0819 |
Lapatinib, Erlotinib, Crizotinib |
Lapatinib, Erlotinib, Crizotinib, Onartuzumab |
MET |
1% |
COSM144187 |
p.G983S |
Substitution - Missense |
0.0819 |
Lapatinib, Erlotinib, Crizotinib |
Lapatinib, Erlotinib, Crizotinib, Onartuzumab |
MET |
1% |
COSM707 |
p.T1010I |
Substitution - Missense |
0.0819 |
Lapatinib, Erlotinib, Crizotinib |
Lapatinib, Erlotinib, Crizotinib, Onartuzumab |
PTEN |
1% |
COSM5154 |
p.R233* |
Substitution - Nonsense |
0.1619 |
Bosutinib, OSI-906, Methotrexate, BIBW2992 |
TGX221, AZD6482, MK-2206, GDC0941 |
PTEN |
1% |
COSM5776 |
p.? |
Unknown |
0.1619 |
Bosutinib, OSI-906, Methotrexate, BIBW2992 |
TGX221, AZD6482, MK-2206, GDC0941 |
PTEN |
1% |
COSM26393 |
p.R130Q |
Substitution - Missense |
0.081 |
Bosutinib, OSI-906, Methotrexate, BIBW2992 |
TGX221, AZD6482, MK-2206, GDC0941 |
PTEN |
1% |
COSM5089 |
p.R173C |
Substitution - Missense |
0.081 |
Bosutinib, OSI-906, Methotrexate, BIBW2992 |
TGX221, AZD6482, MK-2206, GDC0941 |
PTEN |
1% |
COSM133102 |
p.R173H |
Substitution - Missense |
0.081 |
Bosutinib, OSI-906, Methotrexate, BIBW2992 |
TGX221, AZD6482, MK-2206, GDC0941 |
PTEN |
1% |
COSM5159 |
p.Q245* |
Substitution - Nonsense |
0.081 |
Bosutinib, OSI-906, Methotrexate, BIBW2992 |
TGX221, AZD6482, MK-2206, GDC0941 |
PTEN |
1% |
COSM5220 |
p.G251C |
Substitution - Missense |
0.081 |
Bosutinib, OSI-906, Methotrexate, BIBW2992 |
TGX221, AZD6482, MK-2206, GDC0941 |